It was found to increase the expression of β-site APP-cleaving enzyme 1 (BACE1) in an accelerated aging mouse model of dementia and reduce hippocampal Aβ42 levels, which, in turn, could mediate the parallel decline in glial fibrillary acidic protein (GFAP) expression [49]. Here, GFAP is linked to dementia.